John A. Moran Eye Center physicians will teach ophthalmic skills, share research, and present on a wide variety of topics at the 2024 American Academy of Ophthalmology (AAO) annual meeting...
The Ï㽶ÊÓƵ of Utah’s elite H.A. and Edna Benning Medical Society has selected renowned John A. Moran Eye Center researcher Liliana Werner, MD, PhD, for membership as the recipient of...
A new analysis of research conducted at the John A. Moran Eye Center supports further testing to determine if cataracts might someday be reversed with eye drops.
A Moran Eye Center age-related macular degeneration (AMD) patient recently became the first in Utah to test a new gene therapy developed by the Sharon Eccles Steele Center for Translational...
The Achievement Rewards for College Scientists (ARCS) Foundation of Utah is supporting two incoming Moran Eye Center residents with research scholarships for 2024-2025.
Iqbal "Ike" K. Ahmed, MD, FRCSC, director of the Moran Eye Center’s Alan S. Crandall Center for Glaucoma Innovation, ranked No. 1 on the annual Power List of the 100...
The Ï㽶ÊÓƵ of Utah has awarded renowned age-related macular degeneration (AMD) researcher Gregory S. Hageman, PhD, the rank of distinguished professor.
Publishing in the prestigious journal Nature Communications, Moran's latest AMD research points the field away from a liver-produced protein others had identified as a promising therapeutic target.
The Alan S. Crandall Center for Glaucoma Innovation, led by Dr. Ike Ahmed, was created at the John A. Moran Eye Center to lead the field in four areas: surgical...
John A. Moran Eye Center physicians will teach ophthalmic skills and present on a wide variety of research at the upcoming American Academy of Ophthalmology (AAO) annual meeting in San...
The John A. Moran Eye Center recently honored 12 of its Ï㽶ÊÓƵ of Utah faculty scholars who hold endowed chairs and professorships and the generous donors who made the positions...
A device that helps patients keep a steady gaze during eye surgery took the Grand Prize Runner-Up award at the 2023 Bench to Bedside competition presented by the Center for...
Patient testing is underway for a new therapy for age-related macular degeneration (AMD) developed by the John A. Moran Eye Center’s Sharon Eccles Steele Center for Translational Medicine (SCTM).
The Ophthalmologist magazine has named four John A. Moran Eye Center leaders in care and research to its 2023 Power List of the 100 most influential people in ophthalmology worldwide.
